Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mohammad

Showing results (311-320 of 367) with videos related to

Pageof 37
Sort By:
Oncotarget|June 3, 2017
Targeting ERK enhances the cytotoxic effect of the novel PI3K and mTOR dual inhibitor VS-5584 in preclinical models of pancreatic cancerChangwen Ning, Min Liang, Shuang Liu, et al.
Molecular Cancer Therapeutics|June 3, 2010
ErbB-inhibitory protein: a modified ectodomain of epidermal growth factor receptor synergizes with dasatinib to inhibit growth of breast cancer cellsJyoti Nautiyal, Yingjie Yu, Amro Aboukameel, et al.
Neurorehabilitation and Neural Repair|September 11, 2008
Constraint-induced movement therapy results in increased motor map area in subjects 3 to 9 months after strokeLumy Sawaki, Andrew J Butler, Xiaoyan Leng, et al.
Annals of Medicine and Surgery (2012)|April 11, 2025
Diabetes mellitus awareness among students attending a public high school in Kurdistan Region of Iraq: a cross-sectional studyAhmed A Mosa, Hajar Hassan Abdulqadir, Rojeen Chalabi Khalid, et al.
Cancer Biology & Therapy|September 5, 2008
Apogossypolone, a nonpeptidic small molecule inhibitor targeting Bcl-2 family proteins, effectively inhibits growth of diffuse large cell lymphoma cells in vitro and in vivoYuan Sun, Jack Wu, Amro Aboukameel, et al.
Neurorehabilitation|September 18, 2014
Differential patterns of cortical reorganization following constraint-induced movement therapy during early and late period after stroke: A preliminary studyLumy Sawaki, Andrew J Butler, Xiaoyan Leng, et al.
Scientific Reports|November 6, 2015
Targeting the Nuclear Export Protein XPO1/CRM1 Reverses Epithelial to Mesenchymal TransitionAsfar S Azmi, Irfana Muqbil, Jack Wu, et al.
Pancreas|January 22, 1998
Establishment of a human pancreatic tumor xenograft model: potential application for preclinical evaluation of novel therapeutic agentsR M Mohammad, M C Dugan, A N Mohamed, et al.
Oncotarget|May 31, 2011
Network modeling of MDM2 inhibitor-oxaliplatin combination reveals biological synergy in wt-p53 solid tumorsAsfar S Azmi, Sanjeev Banerjee, Shadan Ali, et al.
Oncotarget|October 8, 2016
Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell deathTrinayan Kashyap, Christian Argueta, Amro Aboukameel, et al.
Pageof 37

Showing results (311-320 of 367) with videos related to

Sort By:
Pageof 37
Oncotarget|June 3, 2017
Targeting ERK enhances the cytotoxic effect of the novel PI3K and mTOR dual inhibitor VS-5584 in preclinical models of pancreatic cancerChangwen Ning, Min Liang, Shuang Liu, et al.
Molecular Cancer Therapeutics|June 3, 2010
ErbB-inhibitory protein: a modified ectodomain of epidermal growth factor receptor synergizes with dasatinib to inhibit growth of breast cancer cellsJyoti Nautiyal, Yingjie Yu, Amro Aboukameel, et al.
Neurorehabilitation and Neural Repair|September 11, 2008
Constraint-induced movement therapy results in increased motor map area in subjects 3 to 9 months after strokeLumy Sawaki, Andrew J Butler, Xiaoyan Leng, et al.
Annals of Medicine and Surgery (2012)|April 11, 2025
Diabetes mellitus awareness among students attending a public high school in Kurdistan Region of Iraq: a cross-sectional studyAhmed A Mosa, Hajar Hassan Abdulqadir, Rojeen Chalabi Khalid, et al.
Cancer Biology & Therapy|September 5, 2008
Apogossypolone, a nonpeptidic small molecule inhibitor targeting Bcl-2 family proteins, effectively inhibits growth of diffuse large cell lymphoma cells in vitro and in vivoYuan Sun, Jack Wu, Amro Aboukameel, et al.
Neurorehabilitation|September 18, 2014
Differential patterns of cortical reorganization following constraint-induced movement therapy during early and late period after stroke: A preliminary studyLumy Sawaki, Andrew J Butler, Xiaoyan Leng, et al.
Scientific Reports|November 6, 2015
Targeting the Nuclear Export Protein XPO1/CRM1 Reverses Epithelial to Mesenchymal TransitionAsfar S Azmi, Irfana Muqbil, Jack Wu, et al.
Pancreas|January 22, 1998
Establishment of a human pancreatic tumor xenograft model: potential application for preclinical evaluation of novel therapeutic agentsR M Mohammad, M C Dugan, A N Mohamed, et al.
Oncotarget|May 31, 2011
Network modeling of MDM2 inhibitor-oxaliplatin combination reveals biological synergy in wt-p53 solid tumorsAsfar S Azmi, Sanjeev Banerjee, Shadan Ali, et al.
Oncotarget|October 8, 2016
Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell deathTrinayan Kashyap, Christian Argueta, Amro Aboukameel, et al.
Pageof 37